Phasix™ Resorbable Mesh

Phasix™ Mesh is part of the Bard portfolio supplied by BD, a fully resorbable surgical mesh for hernia repair. BD describes it as a knitted monofilament mesh scaffold made from Poly-4-hydroxybutyrate (P4HB), a biologically derived, fully resorbable material, and states that it is designed to allow for the repair strength of a synthetic mesh along with the remodelling characteristics of a biologic graft. According to BD, the mesh provides a fully resorbable monofilament scaffold for rapid tissue incorporation, offering critical strength during the initial healing phase through its open-pore monofilament structure. BD provides detail on how the material behaves. BD states that the monomer form (4HB) is a naturally occurring human metabolite, and that the mesh predictably resorbs through hydrolysis as P4HB metabolises into biocompatible byproducts (carbon dioxide and water), gradually and predictably degrading within 12 to 18 months. BD reports that as Phasix™ Mesh is remodelled it is replaced with functional tissue, ultimately resulting in a strong repair, and states that it has not been shown to break down in the presence of bacteria, maintaining 100% of its strength at 56 days. For general and hernia surgery teams in Azerbaijan, the relevant interest is a resorbable mesh that aims to combine synthetic repair strength with biologic-type remodelling. Azmed Devices provides manufacturer documentation, registration status, tender support and supply coordination for BD surgical products. Detailed specifications and available configurations are available on request.

Manufacturer: C. R. Bard, Inc. (a BD company) · Reference source: bd.com